BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
So the upper tract data was not as robust as what we had seen in, you know, what we had hoped, but we had seen in lower tract patients, which are predominantly bladder, and it did include some urethra, but predominantly bladder. About 20% of the patients were upper tract, and we didn't limit the enrollment of upper tract.
0
💬
0
Comments
Log in to comment.
There are no comments yet.